Anton Hutter > Venner Shipley LLP > Guildford, England > Lawyer Profile
Venner Shipley LLP Offices
The Surrey Research Park
5 Stirling House
GUILDFORD, SURREY
GU2 7RF
England
- Firm Profile
- Go to...
Anton Hutter
Work Department
Chemical and Life Sciences
Position
Anton is a European and Chartered Patent Attorney, and works in our Guildford office. He is a Partner in our Chemical and Life Sciences team.
Anton specialises in biotechnology, pharmaceutical, chemical and medical device patent matters. In particular, he has a deep understanding of molecular biology, biochemistry, genetics, genomics & proteomics, therapeutic antibodies, immunology, immuno-oncology, plant biotechnology, peptides, biomarkers, bioinformatics, diagnostics, vaccines, stem cells, formulations, chemical engineering, pharmaceuticals and SPC’s. Anton is especially knowledgeable in patenting genome editing techniques, including CRISPR, as well as neurodegenerative disorders (primarily Alzheimer’s disease) and gene therapy inventions.
Anton has gained considerable experience in handling all aspects of patent practice, especially meeting inventors directly, and drafting and prosecuting patent applications before the UKIPO, the EPO and national patent offices. Anton has drafted hundreds of patent applications in the biotechnology, chemical and pharma sectors, and is experienced in managing international patent filing strategies for his clients.
Anton has significant experience of advising clients in relation to patent infringement and validity, freedom-to-operate clearances of third party patents, and providing due diligence opinions. Anton also enjoys complex opposition and appeal work, and regularly attends oral proceedings at the EPO.
Anton works for a broad spectrum of clients, and has extensive experience of working with academic institutions and associated technology transfer departments, university-derived spin-out companies, SME’s, as well as large multinational biotechnology and pharmaceutical companies. He is proactive, and provides his clients with clear, commercially relevant advice. Anton regularly lectures on a variety of IP-related topics, including patenting bioscience inventions.
Memberships
- Fellow of the Chartered Institute of Patent Attorneys
- Member of the European Patent Institute
- European Patent Litigator
- UPC Authorised Representative
Education
Anton graduated from Nottingham University with an Honours degree in Biochemistry & Genetics. He then attended UMIST where he obtained a Masters degree in Bioreactor Systems & Chemical Engineering, in which his research involved the design and construction of expression vectors for use in S. coelicolor. Anton also holds a PhD in Genetic Engineering, in which his research focused on the genetics of ethanol tolerance and production in the yeast, S. cerevisiae. He also has a Certificate in Bioinformatics from Manchester University.
Lawyer Rankings
London > TMT (technology, media and telecoms) > PATMA: Patent attorneys
Venner Shipley LLP is praised by a client for having ‘a diverse team with depth and breadth of knowledge’ across patent-related mandates, covering electronics and software, which is led by Jan Walaski, mechanical and engineering headed up by Ian Grey, and chemistry and life sciences spearheaded by Siân Gill. The firm continues to handle an increasing number of patent applications, with particular expertise in AI and machine learning products; Richard Kennedy leads the firm’s AI IP offering. It also has notable strength in opposition and appeal proceedings before the EPO, and its client roster is broad ranging, including universities, SMEs, and start-ups, as well as multi-national corporations. In Cambridge, managing partner Pawel Piotrowicz is an expert in computer-implemented simulations, and Allie Elend has ‘excellent scientific knowledge’ and supports large pharmaceutical companies. Head of the firm’s Guildford office, Anton Hutter, has significant expertise in patenting antibodies, vaccines, and gene therapy constructs. The team continues to expand, with five new patent attorneys hires since July 2022.